Mylan N V (MYL) Return on Equity ROE from the third quarter 2020 to third quarter 2019 and annually, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Mylan N v   (NASDAQ: MYL)

Mylan N V 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Mylan N V in the third quarter 2020?
Mylan N v achieved a return on average equity (ROE) of 2.25 % in its third quarter 2020, which is below Mylan N V 's average return on equity, which stands at 7.27%.

ROE fell compared to the second quarter 2020, despite the net income growth of 371.32% from the second quarter 2020.

Within the Major Pharmaceutical Preparations industry 44 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2020 from 1911 to 1984.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Equity Change 9.46 % -1.32 % -5.29 % -2.33 % -
Y / Y Net Income Change -2.16 % - - -59.96 % 7.41 %
Net Income (TTM) in Millions 266 271 63 17 48
Return On Equity (TTM) 2.25 % 2.33 % 0.54 % 0.14 % 0.4 %
MYL's Total Ranking # 1984 # 1911 # 2086 # 2666 # 0
Equity (TTM) in Millions 12,548 11,746 11,263 11,884 11,463
Seq. Equity Change 6.83 % 4.29 % -5.23 % 3.67 % -3.69 %
Seq. Net Income Change 371.32 % 89.42 % 1.46 % -89.2 % -

Back to MYL Management Effectiveness >> MYL's 5 Years Annual ROE >> Compare MYL ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 45
Sector # 162
Overall # 1984

Return On Equity Statistics
High Average Low
37.26 %
7.27 %
-60.85 %
(Dec. 31. 2006)   (March 31 2008)





MYL Annual Return On Equity (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Equity in Millions 11,884 12,167 13,308 11,118 9,766
Y / Y Equity Change -2.33 % -8.57 % 19.7 % 13.84 % 198.1 %
Net Income in Millions 17 353 696 480 848
Y / Y Net Income Change -95.23 % -49.35 % 45 % -43.38 % -8.79 %
Return On Equity 0.14 % 2.9 % 5.23 % 4.32 % 8.68 %

Back to MYL Management Effectiveness >> MYL's 5 Years Annual ROE >> Compare MYL ROE to its Competitors




Annual Roe Comment
In 2019 ROE decreased compared to the previous year to 0.14 %, due to deterioration of net income.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MYL's' Return on Equity at Yahoo Finance
MYL's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MYL's Competitors
Subscribers only: Roe for Mylan N V 's Suppliers
Subscribers only: Return On Equity for MYL's Customers




Companies with similar Return On Equity at Sep 30 2020, within Healthcare Sector ROE
Integer Holdings Corporation  6.16 %
Gilead Sciences Inc   6.14 %
Icu Medical Inc  5.79 %
Jazz Pharmaceuticals Plc  5.76 %
Avantor Inc   5.43 %
Staar Surgical Co  5.23 %
Heartbeam Inc   4.64 %
Vanda Pharmaceuticals Inc   4.56 %
Cantel Medical Corp   4.47 %
Integra Lifesciences Holdings Corp  4.10 %
Acadia Healthcare Company Inc   4.09 %
Repligen Corp  4.03 %
Brookdale Senior Living Inc   3.93 %
Becton Dickinson And Company  3.89 %
National Healthcare Corp  3.68 %
Iqvia Holdings Inc   3.30 %
Amneal Pharmaceuticals Inc   2.90 %
Progyny Inc   2.85 %
Eagle Pharmaceuticals inc   2.75 %
Mylan N v   2.25 %
Avanos Medical Inc   2.13 %
Amphastar Pharmaceuticals Inc   1.75 %
Enovis Corp  1.35 %
Surmodics Inc   0.88 %
National Vision Holdings Inc   0.63 %
Agape Atp Corporation  0.61 %

Date modified: 2026-09-26T06:50:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.